Clinical Trial for Colorectal Cancer: 28 Real Stories

28 stories match colorectal cancer and clinical trial. 24 of them mention chemotherapy.

JJ, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: JJ's Patient Story

Patient Info: JJ, Male, Under 40 | Stage IV

Biomarkers: Microsatellite-mutated disease mentioned in clinical-trial context; exact MSI/MMR result not otherwise specified

Metastatic Site: Abdominal wall; lymph nodes; stomach/intestinal outlet…

As of January 2023, JJ was living with incurable Stage IV colon cancer on pembrolizumab/Keytruda clinical-trial infusions every 3 weeks; the trial had kept the abdominal tumor mass from spreading and had helped him live beyond the prognosis he feared, but it was not described as curative.

The Patient Story
OutcomeResponding Well
Cindi, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Cindi's Survivor Story

Patient Info: Cindi, Female, 60s | Stage IV

Metastatic Site: Liver; abdominal lining/peritoneum

As of March 2022, Cindi had no recurrence more than 1 year after a clinical trial with nivolumab, investigational anti-tumor vaccine, chemotherapy, and surgery produced a complete pathologic response with no living cancer cells.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

A Severe Delayed Immune Reaction After Treatment for Metastatic Colon Cancer

Patient Info: Anonymized, Male, 70+ | Stage IV

Metastatic Site: liver

He recovered from repeated episodes of severe cytokine release syndrome after prolonged corticosteroids, completed adjuvant FOLFOX and CV301 without nivolumab, and had no further CRS episodes.

PubMed Central
OutcomeCare Ongoing
Howard, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Howard's Patient Story

Patient Info: Howard Brown, Male, 50s | Stage IV

Metastatic Site: peritoneum|liver

Howard was living with metastatic colon cancer and undergoing CT scans every 90 days, with further treatment depending on whether scans showed recurrence or progression.

AACR
OutcomeLiving With Cancer